1. Home
  2. ZURA vs BNED Comparison

ZURA vs BNED Comparison

Compare ZURA & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$5.01

Market Cap

455.4M

Sector

Health Care

ML Signal

HOLD

Logo Barnes & Noble Education Inc

BNED

Barnes & Noble Education Inc

HOLD

Current Price

$13.20

Market Cap

366.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZURA
BNED
Founded
2022
1965
Country
United States
United States
Employees
40
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
455.4M
366.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ZURA
BNED
Price
$5.01
$13.20
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$13.00
N/A
AVG Volume (30 Days)
1.6M
366.7K
Earning Date
05-14-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.39
Revenue
N/A
$1,610,170,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$32.21
Revenue Growth
N/A
N/A
52 Week Low
$1.12
$5.90
52 Week High
$7.25
$14.75

Technical Indicators

Market Signals
Indicator
ZURA
BNED
Relative Strength Index (RSI) 61.27 63.44
Support Level $4.22 $8.25
Resistance Level $5.82 N/A
Average True Range (ATR) 0.44 0.79
MACD 0.25 0.20
Stochastic Oscillator 69.25 58.59

Price Performance

Historical Comparison
ZURA
BNED

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also a textbook wholesaler and inventory management hardware and software provider. It offers course materials through physical and online bookstores, including new and used print textbooks, rental options, digital textbooks, and publisher-hosted digital courseware. Products are also offered directly to students through Textbooks.com. The majority of the company's revenue is derived from the sale of products through its bookstore locations, including virtual bookstores, and the bookstore affiliated e-commerce websites.

Share on Social Networks: